BioLineRx Ltd. (BLRX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

BioLineRx Ltd.

NASDAQ: BLRX · Real-Time Price · USD
4.00
0.10 (2.56%)
At close: Oct 03, 2025, 3:59 PM
3.80
-5.00%
After-hours: Oct 03, 2025, 07:43 PM EDT

BioLineRx Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
304K 255K 11.75M 4.94M 5.39M 6.86M 4.8M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
72K 34K 6.09M 822K 897K 1.46M 3.69M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
232K 221K 5.66M 4.12M 4.5M 5.4M 1.11M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income
-2.3M -2.39M -4.43M -5.39M -5.77M -4.82M -18.57M -12.36M -9.91M -8.86M -8.4M -7.08M -7.6M -6.08M -6.6M -6.22M -6.51M -5.45M
Interest Income
490K 294K 286K 434K 535K 565K 718K 312K 440K 537K 438K 109K 80K 67K 260K 52K 130K 117K
Pretax Income
-3.94M 5.13M -3.19M -5.82M 484K -696K -13.88M -16.02M -18.55M -12.16M -5.73M -6.85M -7.44M -4.93M -4.3M -5.72M -6.84M -10.19M
Net Income
-3.94M 5.13M -3.19M -5.82M 484K -696K -13.88M -16.02M -18.55M -12.16M -5.73M -6.85M -7.44M -4.93M -4.3M -5.72M -6.84M -10.19M
Selling & General & Admin
209K 989K 5.83M 6.94M 8.04M 7.73M 9.87M 9.63M 6.91M 5.17M 4.93M 2.71M 2.21M 1.64M 1.43M 1.29M 1.37M 1.17M
Research & Development
2.33M 1.62M 1.86M 2.56M 2.23M 2.49M 3.1M 2.73M 3.01M 3.68M 3.43M 4.37M 5.39M 4.43M 5.13M 4.92M 5.14M 4.28M
Other Expenses
n/a n/a 2.4M n/a n/a n/a 1K n/a n/a n/a 39K n/a n/a n/a 42K n/a n/a n/a
Operating Expenses
2.54M 2.61M 10.09M 9.51M 10.27M 10.22M 12.97M 12.36M 9.91M 8.86M 8.4M 7.08M 7.6M 6.08M 6.6M 6.22M 6.51M 5.45M
Interest Expense
276K 420K 4.43M 1.63M 2.08M 929K -932K 837K 1.34M 927K 1.33M 267K 379K 186K 204K 261K 242K 299K
Selling & Marketing Expenses
n/a n/a -8.23M 5.55M 6.42M 6.34M -3.02M 8.13M 5.6M 3.87M 3.35M 1.32M 1.16M 637K 272K 247K 330K 154K
Cost & Expenses
2.61M 2.65M 16.18M 10.33M 11.17M 11.68M 16.66M 12.36M 9.91M 8.86M 8.4M 7.08M 7.6M 6.08M 6.6M 6.22M 6.51M 5.45M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
3.95M 79.86M 79.86M 79.86M 79.84M 72.44M 71.9M 61.94M 61.53M 61.53M 51.6M 49.38M 47.69M 47.68M 44.2M 47.23M 44.61M 37.3M
Shares Outstanding (Diluted)
3.95M 79.86M 79.86M 79.86M 79.84M 72.44M 71.89M 61.94M 61.53M 61.53M 51.6M 49.38M 47.69M 47.68M 44.2M 47.23M 44.61M 37.3M
EPS (Basic)
-1 0.06 -0.04 -0.07 0.01 -0.01 -0.19 -0.26 -0.3 -0.19 -0.06 -0.13 -0.15 -0.08 -0.1 -0.12 -0.15 -0.27
EPS (Diluted)
-1 0.06 -0.04 -0.07 0.01 -0.01 -0.19 -0.26 -0.3 -0.19 -0.06 -0.13 -0.15 -0.08 -0.1 -0.12 -0.15 -0.27
EBITDA
-3.49M 5.71M 3.1M -3.36M 3.04M 1.13M -14.14M -14.96M -17.01M -10.98M -4.59M -6.43M -6.92M -4.57M -3.95M -5.29M -6.42M -9.71M
EBIT
-3.66M 5.55M 1.25M -4.2M 2.57M 233K -14.84M -15.19M -17.21M -11.23M -4.78M -6.58M -7.06M -4.74M -4.12M -5.46M -6.6M -9.89M
Depreciation & Amortization
176K 165K 1.85M 840K 476K 897K 706K 221K 198K 259K 187K 153K 141K 173K 174K 167K 180K 182K